Subtype Specificity of Genetic Loci Associated With Stroke in 16 664 Cases and 32 792 Controls.


Journal

Circulation. Genomic and precision medicine
ISSN: 2574-8300
Titre abrégé: Circ Genom Precis Med
Pays: United States
ID NLM: 101714113

Informations de publication

Date de publication:
07 2019
Historique:
entrez: 16 7 2019
pubmed: 16 7 2019
medline: 17 7 2020
Statut: ppublish

Résumé

Genome-wide association studies have identified multiple loci associated with stroke. However, the specific stroke subtypes affected, and whether loci influence both ischemic and hemorrhagic stroke, remains unknown. For loci associated with stroke, we aimed to infer the combination of stroke subtypes likely to be affected, and in doing so assess the extent to which such loci have homogeneous effects across stroke subtypes. We performed Bayesian multinomial regression in 16 664 stroke cases and 32 792 controls of European ancestry to determine the most likely combination of stroke subtypes affected for loci with published genome-wide stroke associations, using model selection. Cases were subtyped under 2 commonly used stroke classification systems, TOAST (Trial of Org 10172 Acute Stroke Treatment) and causative classification of stroke. All individuals had genotypes imputed to the Haplotype Reference Consortium 1.1 Panel. Sixteen loci were considered for analysis. Seven loci influenced both hemorrhagic and ischemic stroke, 3 of which influenced ischemic and hemorrhagic subtypes under both TOAST and causative classification of stroke. Under causative classification of stroke, 4 loci influenced both small vessel stroke and intracerebral hemorrhage. An EDNRA locus demonstrated opposing effects on ischemic and hemorrhagic stroke. No loci were predicted to influence all stroke subtypes in the same direction, and only one locus (12q24) was predicted to influence all ischemic stroke subtypes. Heterogeneity in the influence of stroke-associated loci on stroke subtypes is pervasive, reflecting differing causal pathways. However, overlap exists between hemorrhagic and ischemic stroke, which may reflect shared pathobiology predisposing to small vessel arteriopathy. Stroke is a complex, heterogeneous disorder requiring tailored analytic strategies to decipher genetic mechanisms.

Sections du résumé

BACKGROUND
Genome-wide association studies have identified multiple loci associated with stroke. However, the specific stroke subtypes affected, and whether loci influence both ischemic and hemorrhagic stroke, remains unknown. For loci associated with stroke, we aimed to infer the combination of stroke subtypes likely to be affected, and in doing so assess the extent to which such loci have homogeneous effects across stroke subtypes.
METHODS
We performed Bayesian multinomial regression in 16 664 stroke cases and 32 792 controls of European ancestry to determine the most likely combination of stroke subtypes affected for loci with published genome-wide stroke associations, using model selection. Cases were subtyped under 2 commonly used stroke classification systems, TOAST (Trial of Org 10172 Acute Stroke Treatment) and causative classification of stroke. All individuals had genotypes imputed to the Haplotype Reference Consortium 1.1 Panel.
RESULTS
Sixteen loci were considered for analysis. Seven loci influenced both hemorrhagic and ischemic stroke, 3 of which influenced ischemic and hemorrhagic subtypes under both TOAST and causative classification of stroke. Under causative classification of stroke, 4 loci influenced both small vessel stroke and intracerebral hemorrhage. An EDNRA locus demonstrated opposing effects on ischemic and hemorrhagic stroke. No loci were predicted to influence all stroke subtypes in the same direction, and only one locus (12q24) was predicted to influence all ischemic stroke subtypes.
CONCLUSIONS
Heterogeneity in the influence of stroke-associated loci on stroke subtypes is pervasive, reflecting differing causal pathways. However, overlap exists between hemorrhagic and ischemic stroke, which may reflect shared pathobiology predisposing to small vessel arteriopathy. Stroke is a complex, heterogeneous disorder requiring tailored analytic strategies to decipher genetic mechanisms.

Identifiants

pubmed: 31306060
doi: 10.1161/CIRCGEN.118.002338
pmc: PMC7477820
mid: NIHMS1621357
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e002338

Subventions

Organisme : Wellcome Trust
ID : WT072952
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : K23 NS086873
Pays : United States
Organisme : Wellcome Trust
ID : WT084724MA
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 085475/B/08/Z
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS100178
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS105150
Pays : United States
Organisme : Wellcome Trust
ID : 085475/Z/08/Z
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS103924
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK072488
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS069208
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/16/4/32218
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL088521
Pays : United States

Références

Am J Hum Genet. 2017 Jul 6;101(1):5-22
pubmed: 28686856
Nat Genet. 2016 Aug;48(8):856-66
pubmed: 27322543
Nat Genet. 2012 Feb 05;44(3):328-33
pubmed: 22306652
Am J Hum Genet. 2014 Apr 3;94(4):511-21
pubmed: 24656865
Nat Genet. 2018 Sep;50(9):1225-1233
pubmed: 29892015
Nat Genet. 2017 Jul;49(7):1113-1119
pubmed: 28530674
J Clin Neurosci. 2014 Jan;21(1):28-32
pubmed: 24120708
Neurology. 2001 May 22;56(10):1273-7
pubmed: 11376172
Circulation. 2006 Jul 4;114(1 Suppl):I319-26
pubmed: 16820593
Lancet. 2017 Feb 11;389(10069):641-654
pubmed: 27637676
Neurology. 2017 Oct 24;89(17):1829-1839
pubmed: 28954878
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14367-72
pubmed: 9826706
Circulation. 2004 Oct 12;110(15):2233-40
pubmed: 15466627
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Hum Mol Genet. 2012 May 1;21(9):2102-10
pubmed: 22286173
Neurology. 2012 Dec 4;79(23):2275-82
pubmed: 23175721
Lancet Neurol. 2016 Feb;15(2):174-184
pubmed: 26708676
Nat Genet. 2011 Sep 11;43(10):940-7
pubmed: 21909108
Stroke. 2007 Nov;38(11):2979-84
pubmed: 17901381
PLoS One. 2015 Oct 21;10(10):e0139262
pubmed: 26488411
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Lancet Neurol. 2012 Nov;11(11):951-62
pubmed: 23041239
Nat Genet. 2018 Apr;50(4):524-537
pubmed: 29531354
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118

Auteurs

Matthew Traylor (M)

Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge (M.T., H.S.M.).
William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London (M.T.).

Christopher D Anderson (CD)

Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
J. Philip Kistler Stroke Research Center, Department of Neurology (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Division of Neurocritical Care and Emergency Neurology, Department of Neurology (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Program in Medical and Population Genetics, Broad Inst, Cambridge, MA (C.D.A., J.R.).

Loes C A Rutten-Jacobs (LCA)

German Center for Neurodegenerative Diseases, Population Health Sciences, Bonn, Germany (L.C.A.R.-J.).

Guido J Falcone (GJ)

Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT (G.J.F.).

Mary E Comeau (ME)

Department of Biostatistical Sciences, Division of Public Health Sciences, School of Medicine, Wake Forest University, Winston-Salem, NC (M.E.C., C.D.L.).

Hakan Ay (H)

Stroke Service (H.A.), Massachusetts General Hospital, Boston.
A.A. Martinos Center for Biomedical Imaging, Department of Radiology (H.A.), Massachusetts General Hospital, Boston.

Cathie L M Sudlow (CLM)

Center for Clinical Brain Sciences, University of Edinburgh (C.L.M.S.).
Usher Institute of Population Health Sciences and Informatics, Nine Bioquarter, Edinburgh, United Kingdom (C.L.M.S.).

Huichun Xu (H)

Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X., B.D.M.,), University of Maryland School of Medicine.

Braxton D Mitchell (BD)

Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X., B.D.M.,), University of Maryland School of Medicine.
Geriatrics Research and Education Clinical Center, Baltimore Veterans Administration Medical Center (B.D.M.).

John W Cole (JW)

Department of Neurology (S.J.K., J.W.C), University of Maryland School of Medicine.
Department of Neurology, Veterans Affairs Medical Center, Baltimore, MD (J.W.C., S.J.K).

Kathryn Rexrode (K)

Channing Division of Network Medicine and Division of Women's Health, Department of Medicine, Brigham and Women's Hospital, Boston, MA (K.R.).

Jordi Jimenez-Conde (J)

Neurovascular Research Unit, Department of Neurology (J.J.-C.), Institut Municipal d'Investigacio´ Medica-Hospital del Mar, Universitat Autonoma de Barcelona, Spain.
Program in Inflammation and Cardiovascular Disorders (J.J.-C.), Institut Municipal d'Investigacio´ Medica-Hospital del Mar, Universitat Autonoma de Barcelona, Spain.

Reinhold Schmidt (R)

Department of Neurology, Medical University of Graz, Austria (R. Schmidt).

Raji P Grewal (RP)

Neuroscience Institute, Saint Francis Medical Center, School of Health and Medical Sciences, Seton Hall University, South Orange, NJ (R.P.G.).

Ralph Sacco (R)

Department of Neurology, Miller School of Medicine, University of Miami, FL (R. Sacco, T.R.).

Marta Ribases (M)

Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (M.R.).
Department of Psychiatry, Hospital Universitari Vall d'Hebron (M.R.).
Biomedical Network Research Center on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain (M.R.).

Tatjana Rundek (T)

Department of Neurology, Miller School of Medicine, University of Miami, FL (R. Sacco, T.R.).

Jonathan Rosand (J)

Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
J. Philip Kistler Stroke Research Center, Department of Neurology (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Division of Neurocritical Care and Emergency Neurology, Department of Neurology (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Program in Medical and Population Genetics, Broad Inst, Cambridge, MA (C.D.A., J.R.).

Martin Dichgans (M)

Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität München (M.D., R.M.).
Munich Cluster for Systems Neurology (SyNergy), Germany (M.D.).

Jin-Moo Lee (JM)

Department of Neurology, Radiology, and Biomedical Engineering, Washington University School of Medicine, St Louis, MO (J.-M.L.).

Carl D Langefeld (CD)

Department of Biostatistical Sciences, Division of Public Health Sciences, School of Medicine, Wake Forest University, Winston-Salem, NC (M.E.C., C.D.L.).

Steven J Kittner (SJ)

Department of Neurology (S.J.K., J.W.C), University of Maryland School of Medicine.
Department of Neurology, Veterans Affairs Medical Center, Baltimore, MD (J.W.C., S.J.K).

Hugh S Markus (HS)

Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge (M.T., H.S.M.).

Daniel Woo (D)

Department of Neurology and Rehabilitation Medicine and Comprehensive Stroke Center, University of Cincinnati, OH (D.W.).

Rainer Malik (R)

Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität München (M.D., R.M.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH